Log in to save to my catalogue

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized con...

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized con...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2691789211

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial

About this item

Full title

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial

Publisher

Cambridge, UK: Cambridge University Press

Journal title

International psychogeriatrics, 2022-10, Vol.34 (10), p.905-917

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

ABSTRACTObjectivesTo examine the costs and cost-effectiveness of mirtazapine compared to placebo over 12-week follow-up. DesignEconomic evaluation in a double-blind randomized controlled trial of mirtazapine vs. placebo. SettingCommunity settings and care homes in 26 UK centers. ParticipantsPeople with probable or possible Alzheimer’s disease and a...

Alternative Titles

Full title

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2691789211

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2691789211

Other Identifiers

ISSN

1041-6102

E-ISSN

1741-203X

DOI

10.1017/S1041610222000436

How to access this item